Agilent Technologies Price to Book Ratio 2010-2025 | A
Historical price to book ratio values for Agilent Technologies (A) over the last 10 years. The current price to book ratio for Agilent Technologies as of August 19, 2025 is 5.47.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Agilent Technologies Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-08-19 | 120.11 | 5.56 | |
| 2025-04-30 | 107.37 | $21.61 | 4.97 |
| 2025-01-31 | 150.88 | $21.13 | 7.14 |
| 2024-10-31 | 129.52 | $20.68 | 6.26 |
| 2024-07-31 | 140.32 | $20.53 | 6.83 |
| 2024-04-30 | 135.74 | $21.31 | 6.37 |
| 2024-01-31 | 128.66 | $21.12 | 6.09 |
| 2023-10-31 | 102.05 | $20.01 | 5.10 |
| 2023-07-31 | 119.98 | $18.97 | 6.32 |
| 2023-04-30 | 133.18 | $19.60 | 6.80 |
| 2023-01-31 | 149.31 | $18.95 | 7.88 |
| 2022-10-31 | 135.63 | $17.97 | 7.55 |
| 2022-07-31 | 131.24 | $17.20 | 7.63 |
| 2022-04-30 | 116.52 | $17.13 | 6.80 |
| 2022-01-31 | 135.89 | $17.18 | 7.91 |
| 2021-10-31 | 153.41 | $17.84 | 8.60 |
| 2021-07-31 | 149.08 | $16.32 | 9.13 |
| 2021-04-30 | 129.85 | $15.87 | 8.18 |
| 2021-01-31 | 116.58 | $15.75 | 7.40 |
| 2020-10-31 | 98.88 | $15.92 | 6.21 |
| 2020-07-31 | 93.13 | $16.12 | 5.78 |
| 2020-04-30 | 73.96 | $15.48 | 4.78 |
| 2020-01-31 | 79.45 | $15.64 | 5.08 |
| 2019-10-31 | 72.74 | $15.37 | 4.73 |
| 2019-07-31 | 66.51 | $15.31 | 4.34 |
| 2019-04-30 | 75.06 | $16.17 | 4.64 |
| 2019-01-31 | 72.57 | $15.84 | 4.58 |
| 2018-10-31 | 61.67 | $14.37 | 4.29 |
| 2018-07-31 | 62.73 | $14.32 | 4.38 |
| 2018-04-30 | 62.29 | $14.34 | 4.34 |
| 2018-01-31 | 69.42 | $15.83 | 4.39 |
| 2017-10-31 | 64.17 | $15.02 | 4.27 |
| 2017-07-31 | 56.28 | $14.32 | 3.93 |
| 2017-04-30 | 51.71 | $13.63 | 3.79 |
| 2017-01-31 | 45.88 | $13.35 | 3.44 |
| 2016-10-31 | 40.70 | $13.10 | 3.11 |
| 2016-07-31 | 44.83 | $13.41 | 3.34 |
| 2016-04-30 | 38.03 | $12.82 | 2.97 |
| 2016-01-31 | 34.89 | $12.34 | 2.83 |
| 2015-10-31 | 34.90 | $12.56 | 2.78 |
| 2015-07-31 | 37.74 | $12.37 | 3.05 |
| 2015-04-30 | 38.03 | $12.50 | 3.04 |
| 2015-01-31 | 34.64 | $12.62 | 2.74 |
| 2014-10-31 | 36.17 | $15.83 | 2.28 |
| 2014-07-31 | 36.62 | $16.94 | 2.16 |
| 2014-04-30 | 35.20 | $16.90 | 2.08 |
| 2014-01-31 | 37.78 | $16.31 | 2.32 |
| 2013-10-31 | 32.91 | $15.88 | 2.07 |
| 2013-07-31 | 28.93 | $14.47 | 2.00 |
| 2013-04-30 | 26.73 | $15.39 | 1.74 |
| 2013-01-31 | 28.80 | $15.42 | 1.87 |
| 2012-10-31 | 23.09 | $14.99 | 1.54 |
| 2012-07-31 | 24.50 | $13.96 | 1.75 |
| 2012-04-30 | 26.92 | $13.58 | 1.98 |
| 2012-01-31 | 27.04 | $12.93 | 2.09 |
| 2011-10-31 | 23.60 | $12.44 | 1.90 |
| 2011-07-31 | 26.85 | $12.10 | 2.22 |
| 2011-04-30 | 31.78 | $11.38 | 2.79 |
| 2011-01-31 | 26.64 | $9.68 | 2.75 |
| 2010-10-31 | 22.16 | $9.35 | 2.37 |
| 2010-07-31 | 17.78 | $8.12 | 2.19 |
| 2010-04-30 | 23.09 | $7.56 | 3.05 |
| 2010-01-31 | 17.85 | $7.47 | 2.39 |
| 2009-10-31 | 15.75 | $7.27 | 2.17 |
| 2009-07-31 | 14.79 | $7.21 | 2.05 |
| 2009-04-30 | 11.63 | $7.05 | 1.65 |
| 2009-01-31 | 11.51 | $7.45 | 1.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.562B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Neogen (NEOG) | United States | $1.203B | 19.10 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |